NCT03308812 (MECA) is a NA clinical trial of Health360x in Cardiovascular Diseases, sponsored by Emory University.

Who is sponsoring NCT03308812?

NCT03308812 is sponsored by Emory University.

What drugs are being tested in NCT03308812?

Interventions in NCT03308812: Health360x, Health Coach.

What condition does NCT03308812 study?

NCT03308812 studies Cardiovascular Diseases.

Is NCT03308812 still recruiting?

NCT03308812 is currently completed. Last updated 25 March 2020.

Last reviewed 2020-03-25 · How we verify

NCT03308812: MECA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project

Completed NA Last updated 25 March 2020

What this trial tests

NA trial testing Health360x in Cardiovascular Diseases in 150 participants. Completed in 30 January 2020.

Timeline

25 July 2017

Primary endpoint
30 January 2020

30 January 2020

Quick facts

Lead sponsor	Emory University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	25 July 2017
Primary completion	30 January 2020
Estimated completion	30 January 2020
Sites	3 locations across United States

Drugs / interventions tested

Health360x
Health Coach

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Emory University

Who can join

Adults 21 to 70, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will recruit from participants in the Morehouse-Emory Cardiovascular (MECA) study for a clinical intervention examining cardiac outcomes between participants who are randomized to received Health360x (a web-based and mobile-based application) or Health360x plus personalized health coaching. Participants will receive instruction on using the Health360x application and will use Health360x alone or Health360x with a health coach for 6 months. Measures of cardiovascular health will be assessed at baseline and after the 6 month long intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study.
Islam SJ, Kim JH, Topel M, Liu C, et al · · 2020 · cited 21× · PMID 32340530 · DOI 10.1161/jaha.119.015247
Identifying neighbourhood and individual resilience profiles for cardiovascular health: a cross-sectional study of blacks living in the Atlanta metropolitan area.
Ko YA, Shen J, Kim JH, Topel M, et al · · 2021 · cited 5× · PMID 34330849 · DOI 10.1136/bmjopen-2020-041435

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Emory University trials

Trials by the same sponsor.

NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03308812 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emory University
Last refreshed: 25 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03308812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing